홈 › 급성 골수성 백혈병 › 캘리포니아

캘리포니아의 급성 골수성 백혈병 임상 시험

급성 골수성 백혈병 관련 연구 79개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.

캘리포니아의 도시

공식 연구 텍스트(영어)

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte

피험자 모집 중1상

65세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT06552416

Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent

UCLA Jonsson Comprehensive Cancer Center, Los Angeles
UCI Health Chao Family Comprehensive Cancer Center, Orange
University of California Davis Comprehensive Cancer Center, Sacramento

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07304011

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
외 17개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06317649

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

University of California, Fresno, Clovis
University of California, San Diego, La Jolla
Cedars-Sinai Medical Center, Los Angeles
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07007312

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

City of Hope, Duarte

피험자 모집 중1/2상건강한 지원자 환영

12세 ~ 120세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT05436418

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Cedars-Sinai Medical Center, Los Angeles
Kaiser Permanente-Oakland, Oakland
Kaiser Permanente-Roseville, Roseville
외 3개

피험자 모집 중2상

18세 ~ 59세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT05554406

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

City of Hope Medical Center, Duarte

피험자 모집 중1상

18세 ~ 75세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06996119

CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

City of Hope Medical Center, Duarte

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT05672147

HPC Offered for PRESERVE Expansion

City of Hope, Duarte

피험자 모집 중관찰 연구

12세 ~ 80세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07145411

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

US-Los Angeles CA-UCLA, Los Angeles
US-San Francisco CA-UCSF, San Francisco

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07223814

A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

City of Hope Center Medical Center, Duarte

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07751991

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
외 22개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

City of Hope, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Irvine

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
외 19개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT05564390

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

City of Hope Comprehensive Cancer Center - Duarte, Duarte
University of California Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT05429632

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

피험자 모집 중1상

18세 ~ 70세 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06287944

Study of REM-422 in Patients With AML or Higher Risk MDS

City of Hope, Duarte

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06297941

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

City of Hope, Duarte
UCLA, Los Angeles

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT05143996

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Cedars-Sinai Medical Center, Los Angeles
Kaiser Permanente-Oakland, Oakland
Kaiser Permanente-Roseville, Roseville
외 2개

피험자 모집 중2상

18세 ~ 59세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

UCSF Medical Center-Parnassus, San Francisco

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06672146

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

City of Hope Medical Center, Duarte

피험자 모집 중2상건강한 지원자 환영

18세 ~ 75세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT06059391

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

City of Hope Comprehensive Cancer Center, Duarte

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT06969430

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

UCSF Medical Center-Mission Bay, San Francisco

피험자 모집 중1상

21세 이하 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07012044

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

City of Hope Medical Center, Duarte

피험자 모집 중1상건강한 지원자 환영

18세 ~ 75세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07020533

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Rady Children's Hospital, San Diego

피험자 모집 중1상

1세 ~ 30세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT06177067

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

City of Hope National Medical Center /ID# 279568, Duarte

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07581002

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

University of California, Davis Comprehensive Cancer Center, Sacramento

피험자 모집 중1상

18세 ~ 85세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT06834282

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

Clinical Trial Site, Duarte

피험자 모집 중3상

12세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07211958

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS

City of Hope, Duarte

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06533761

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

City of Hope Medical Center, Duarte

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06543381

A Study of Revumenib and Mezigdomide in People With Leukemia

City of Hope Cancer Center (Data collection only), Duarte

피험자 모집 중1/2상

12세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT07356154

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

City of Hope Medical Center, Duarte

피험자 모집 중1상

2세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT06575296

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

City of Hope National Medical Center, Duarte

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT06846606

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

피험자 모집 중2상

2세 ~ 22세 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06128070

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

Stanford University, Palo Alto

피험자 모집 중1상

2세 ~ 30세 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT05188170

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07582172

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Keck School of Medicine of USC, Los Angeles
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT04256317

Individualized AML Treatment

City of Hope Medical Center, Duarte

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT07613385

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Lucile Packard Children's Hospital /ID# 276015, Palo Alto

피험자 모집 중1상

6 Months – 17 Years · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07306832

A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

City of Hope Medical Center, Duarte

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06763341

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.